{"listing":{"listing_type":"company","name":"Rejuvenation Technologies Inc.","slug":"rejuvenation-technologies-inc","tagline":"mRNA therapeutics to extend healthspan entering clinical trials","description":"Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.\n\nRejuvenation Technologies Inc. is a Y Combinator company (Summer 2018). YC-listed status: Active.","url":"https://rejuvenationtech.com/","is_stealth":false,"normalized_domain":"rejuvenationtech.com","normalized_url_key":"rejuvenationtech.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/8570f907143e200c57848585eb12a16271d3643f.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/rejuvenation-technologies-inc","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Anti-Aging","Gene Therapy","Nanomedicine"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:17:37.982Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2018","Anti-Aging","Gene Therapy","Nanomedicine"],"one_liner_for_search":"Rejuvenation Technologies Inc. — mRNA therapeutics to extend healthspan entering clinical trials (Y Combinator Summer 2018)","canonical_facts":["Y Combinator batch: Summer 2018","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Rejuvenation Technologies Inc., Rejuvenation Technologies","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:17:37.982Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"anti-aging","name":"Anti-Aging","note":null,"profile_url":"/industries/anti-aging"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/industries/nanomedicine"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}]}}